In addition to shaping ARLG’s early development, John Bartlett, M.D. designed and led the original Mentoring Committee. This fellowship is named in honor of a colleague, mentor, and friend whose legacy includes unparalleled achievements and a commitment to supporting the work of early-career researchers.
ARLG shares John’s dedication to combating the threat of antibacterial resistance by providing mentorship and guidance to the next generation of infectious diseases researchers. The goal of the Dr. John G. Bartlett ARLG Fellowship is to inspire and support work that will continue to advance the science of antibacterial resistance well into the future.
About the Fellowship
The Dr. John G. Bartlett ARLG Fellowship lasts up to two years and is a fully funded, competitive opportunity to acquire expertise in antibacterial resistance clinical research. The ARLG Fellowship is designed for MD Infectious Disease (ID) fellows interested in pursuing research, training, and a subsequent career in the patient-oriented study of antibacterial resistance. Recipients will be integrated into the ARLG mission and programs.
The Bartlett ARLG Fellowship is not accepting applications at this time. Due to the timing of the ARLG grant cycle, applications may not re-open until 2026. Please check back periodically for updates.
If you have questions about this opportunity, please contact us at ARLG_Network@dm.duke.edu.
Recipients of the award will receive:
- Salary for up to two years of ID fellowship.
- Mentoring in antibacterial resistance research.
- Formal training in epidemiology or statistics at the Duke University School of Medicine Clinical Research Training Program, or an equivalent program at another institution. Costs for this epidemiology and statistics coursework will be paid by the ARLG.
- Mentoring from senior mentors who are part of the ARLG.
- Training in confidentiality, patient safety, and regulatory affairs.
- Access to ARLG Virtual Biorepository bacterial strains that can be used to support proposed research.
ARLG is committed to a community of learning where fellows are supported in their professional and intellectual goals and pursuits.

“ARLG is not merely a funding mechanism; rather, it is a community of scientists who ardently pursue improved human health through a better understanding of the optimal prevention, detection, and management of antibacterial resistance.”
Judith A. Anesi, MD
University of Pennsylvania Perelman School of Medicine
